BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35006122)

  • 21. Comparison of [
    Chen H; Pang Y; Li J; Kang F; Xu W; Meng T; Shang Q; Zhao J; Guan Y; Wu H; Xie F; Wang J; Sun L
    Eur Radiol; 2023 Feb; 33(2):1329-1341. PubMed ID: 35976396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT Findings of Abdominal Leiomyosarcoma.
    Güzel Y; Can C; Söğütçü N; Gündeş E; Gündoğan C
    Clin Nucl Med; 2021 Dec; 46(12):e594-e597. PubMed ID: 34735413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
    Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
    Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Breast Lymphoma Detected by 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT.
    Tao Y; Wang F; Chen L; Huang Z
    Clin Nucl Med; 2022 Apr; 47(4):339-341. PubMed ID: 35020639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accurate preoperative staging with [
    Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
    Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of 68Ga-FAPI PET/CT for Detecting Myeloid Sarcoma of the Breast and Assessing Early Response to Chemotherapy.
    Wu S; Lin Z; Shang Q; Pang Y; Chen H
    Clin Nucl Med; 2022 Jun; 47(6):549-550. PubMed ID: 35025784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.
    Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Arslan E; Çermik TF; Ergül N
    Nucl Med Commun; 2023 Oct; 44(10):896-899. PubMed ID: 37450605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer.
    Kiran MY; Has Simsek D; Sanli Y; Kuyumcu S
    Clin Nucl Med; 2023 Feb; 48(2):e87-e88. PubMed ID: 36607380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 68Ga-FAPI PET/CT Imaging of Multiple Muscle Metastases of Pancreatic Cancer.
    Gong W; Yang X; Wu J; Ou L; Zhang C
    Clin Nucl Med; 2022 Jan; 47(1):73-75. PubMed ID: 34874351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 68Ga-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor.
    Qiu L; Lan L; Liu H; Deng J; Chen Y
    Clin Nucl Med; 2022 Mar; 47(3):226-227. PubMed ID: 34392281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.
    Fu H; Fu J; Huang J; Pang Y; Chen H
    Clin Nucl Med; 2021 Nov; 46(11):940-942. PubMed ID: 34034326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma: A Case Report.
    Pang Y; Hao B; Shang Q; Sun L; Chen H
    Clin Nucl Med; 2020 Jul; 45(7):566-567. PubMed ID: 32371618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.
    Gündoğan C; Kömek H; Can C; Yildirim ÖA; Kaplan İ; Erdur E; Poyraz K; Güzel Y; Oruç Z; Çakabay B
    Nucl Med Commun; 2022 Jan; 43(1):64-72. PubMed ID: 34661379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
    Elboga U; Sahin E; Cayirli YB; Okuyan M; Aktas G; Haydaroglu Sahin H; Dogan I; Kus T; Akkurd DM; Cimen U; Mumcu V; Kilbas B; Celen YZ
    Tomography; 2022 Feb; 8(1):293-302. PubMed ID: 35202189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A head-to-head comparison of
    Qin C; Liu F; Huang J; Ruan W; Liu Q; Gai Y; Hu F; Jiang D; Hu Y; Yang K; Lan X
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3228-3237. PubMed ID: 33609152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of 68Ga-FAPI PET/CT for Evaluation of Peritoneal Carcinomatosis Before and After Cytoreductive Surgery.
    Zhao L; Pang Y; Wei J; Hao B; Chen H
    Clin Nucl Med; 2021 Jun; 46(6):491-493. PubMed ID: 33782310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor.
    Gu B; Luo Z; He X; Wang J; Song S
    Clin Nucl Med; 2020 Nov; 45(11):865-867. PubMed ID: 32969904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superiority of [
    Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
    Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.